As the coronavirus pandemic continues to spread around the world, scientists and researchers are scrambling for answers about what type of drug regimens could help slow or stop the illness. <\/p>\n
But while some government leaders have already been cavalier about announcing potential treatments<\/u><\/a>, at least one Canadian doctor wants to run clinical trials on cannabinoids to find out if the cannabis compounds can help COVID-19 patients reduce inflammation and boost their immune systems.<\/p>\n \u201cWhat we know from medical cannabis over the course of the literature and the experience we\u2019ve had in Canada over the years is that there are known anti-inflammatory properties that cannabinoids have \u2014 cannabinoids being the active ingredients that come from the cannabis plant,\u201d Dr. Mohan Cooray, president and CEO of the physician-led online medical cannabis retailer Cannalogue told <\/u>The Toronto Sun<\/em><\/u><\/a>. <\/p>\n \u201cOn top of that, we know from a medical standpoint that these active ingredients have immunomodulatory properties, meaning that they augment the immune system to make it better\u2026 and we\u2019ve seen this in diseases such as Crohn\u2019s disease, rheumatoid arthritis, and multiple sclerosis that medical cannabis functions as a naturally occurring immunomodulator.\u201d<\/p>\n